High transcytosis of melanotransferrin (P97) across the blood-brain barrier

Journal of Neurochemistry

Volumn 83, Issue 4, 2002, Pages 924-933

  Demeule, Michel ^a   Poirier, Julie ^a   Jodoin, Julie ^a   Bertrand, Yanick ^a   Desrosiers, Richard R ^a   Dagenais, Claude ^a   Nguyen, Tran ^a   Lanthier, Julie ^a   Gabathuler, Reinhard ^b   Kennard, Malcolm ^b   Jefferies, Wilfred A ^c   Karkan, Delara ^b   Tsai, Sam ^b   Fenart, Laurence ^d   Cecchelli, Roméo ^d   Béliveau, Richard ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b BIOMARIN PHARMACEUTICAL INC   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITÉ D'ARTOIS   (France)

Author keywords

Blood brain barrier; Low density lipoprotein receptor related protein; Melanotransferrin; P97; Transcytosis; Transferrin

Indexed keywords

HOLOTRANSFERRIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MELANOTRANSFERRIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PERFUSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; FEMALE; MALE; MONOLAYER CULTURE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN STABILITY; PROTEIN TRANSPORT; SEQUENCE HOMOLOGY; TRANSCYTOSIS;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARIES; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IODINE RADIOISOTOPES; LDL-RECEPTOR RELATED PROTEIN 1; MALE; MICE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; RATS; SUCROSE; TRANSFERRIN;

ANIMALIA; BOVINAE;

EID: 18744415035     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01201.x     Document Type: Article

References (41)

1. Alemany R., Vila M. R., Franci C., Egea G., Real F. X. and Thomson T. M. (1993) Glycosyl phosphatidylinositol membrane anchoring of melanotransferrin (p97): Apical compartmentalization in intestinal epithelial cells. J. Cell. Sci. 104, 1155-1162.
2. Baker E. N., Baker H. M., Smith C. A., Stebbins M. R., Kahn M., Hellstrom K. E. and Hellstrom I. (1992) Human melanotransferrin (p97) has only one functional iron-binding site. FEBS Lett. 298, 215-218.
3. Bickel U., Yoshikawa T. and Pardridge W. M. (2001) Delivery of peptides and proteins through the blood-brain barrier. Adv. Drug Deliv. Rev. 46, 247-279.
4. Brown J. P., Woodbury R. G., Hart C. E., Hellstrom I. and Hellstrom K. E. (1981) Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc. Natl Acad. Sci. USA 78, 539-543.
5. Brown J. P., Hewick R. M., Hellstrom I., Hellstrom K. E., Doolittle R. F. and Dreyer W. J. (1982) Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature 296, 171-173.
6. Bu G. and Rennke S. (1996) Receptor-associated protein is a folding chaperone for low-density lipoprotein receptor-related protein. J. Biol. Chem. 271, 22218-22224.
7. Bu G. and Schwartz A. L. (1998) RAP, a novel type of ER chaperone. Trends Cell Biol. 8, 272-276.
8. Dagenais C., Rousselle C., Pollack G. M. and Scherrmann J. M. (2000) Development of an in situ mouse brain perfusion model and its application to mdrla P-glycoprotein-deficient mice. J. Cereb. Blood Flow Metab. 20, 381-386.
9. Dallaire L., Tremblay L. and Béliveau R. (1991) Purification and characterization of metabolically active capillaries of the blood-brain barrier. Biochem. J. 276, 745-752.
10. Dehouck M. P., Jolliet-Riant P., Bree F., Fruchart J. C., Cecchelli R. and Tillement J. P. (1992) Drug transfer across the blood-brain barrier: Correlation between in vitro and in vivo models. J. Neurochem. 58, 1790-1797.
11. Dehouck B., Fenart L., Dehouck M. P., Pierce A., Torpier G. and Cecchelli R. (1997) A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier. J. Cell. Biol. 138, 877-889.
12. Demeule M., Shedid D., Beaulieu É., Del Maestro R. F., Moghrabi A., Ghosn P. B., Moumdjian R., Berthelet F. and Béliveau R. (2001) Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors. Int. J. Cancer 93, 62-66.
13. Descamps L., Dehouck M. P., Torpier G. and Cecchelli R. (1996) Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am. J. Physiol. 270, H1149-H1158.
14. Fillebeen C., Descamps L., Dehouck M. P., Fenart L., Benaissa M., Spik G., Cecchelli R. and Pierce A. (1999) Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J. Biol. Chem. 274, 7011-7017.
15. Food M. R., Rothenberger S., Gabathuler R., Haidl I. D., Reid G. and Jefferies W. A. (1994) Transport and expression in human melanomas of a transferrin-like glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 269, 3034-3040.
16. Frank H. J., Pardridge W. M., Morris W. L., Rosenfeld R. G. and Choi T. B. (1986) Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels. Diabetes 35, 654-661.
17. Hussain M. M. (2001) Structural, biochemical and signaling properties of the low-density lipoprotein receptor gene family. Front. Biosci. 6, D417-D428.
18. Jefferies W. A., Food M. R., Gabathuler R., Rothenberger S., Yamada T., Yasuhara O. and McGeer P. L. (1996) Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Res. 712, 122-126.
19. Johnsson B., Lofas S. and Lindquist G. (1991) Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem. 198, 268-277.
20. Kennard M. L., Feldman H., Yamada T. and Jefferies W. A. (1996) Serum levels of the iron binding protein p97 are elevated in Atzheimer's disease. Nat. Med. 2, 1230-1235.
21. Kim D. K., Seo M. Y., Lim S. W., Kim S., Kim J. W., Carroll B. J., Kwon D. Y., Kwon T. and Kang S. S. (2001) Serum melanotransferrin, p97 as a biochemical marker of Atzheimer's disease. Neuropsychopharmacology 25, 84-90.
22. Kusuhara H. and Sugiyama Y. (2001) Efflux transport systems for drugs at the blood-brain barrier and blood - Cerebrospinal fluid barrier (Part 1). Drug Discov. Today 6, 150-156.
23. Laemmli U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
24. Liu C. X., Li Y., Obermoeller-McCormick L. M., Schwartz A. L. and Bu G. (2001) The putative tumor suppressor 1rp1b, a novel member of the low density lipoprotein (ldl) receptor family, exhibits both overlapping and distinct properties with the ldl receptor-related protein. J. Biol. Chem. 276, 28889-28896.
25. Pardridge W. M. (1999) Blood-brain barrier biology and methodology. J. Neurovirol. 5, 556-569.
26. Pardridge W. M., Buciak J. L. and Friden P. M. (1991) Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J. Pharmacol. Exp. Ther. 259, 66-70.
27. Pardridge W. M., Wu D. and Sakane T. (1998) Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration. Pharm. Res. 15, 576-582.
28. Qiu Z., Strickland D. K., Hyman B. T. and Rebeck G. W. (2001) Elevation of LDL receptor-related protein levels via ligand interactions in Alzheimer's disease and in vitro. J. Neuropathol. Exp. Neurol. 60, 430-440.
29. Richardson D. R. (2000) The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell. Eur J. Biochem. 267, 1290-1298.
30. Rose T. M., Plowman G. D., Teplow D. B., Dreyer W. J., Hellstrom K. E. and Brown J. P. (1986) Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc. Natl Acad. Sci. USA 83, 1261-1265.
31. Rothenberger S., Food M. R., Gabathuler R., Kennard M. L., Yamada T., Yasuhara O., McGeer P. L. and Jefferies W. A. (1996) Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium. Brain Res. 712, 117-121.
32. Sekyere E. and Richardson D. R. (2000) The membrane-bound transferrin homologue melanotransferrin: Roles other than iron transport? FEBS Lett. 483, 11-16.
33. 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489-1499.
34. Triguero D., Buciak J. and Pardridge W. M. (1990) Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J. Neurochem. 54, 1882-1888.
35. Tsuji A. and Tamai I. (1999) Carrier-mediated or specialized transport of drugs across the blood-brain barrier. Adv. Drug Deliv. Rev. 36, 277-290.
36. Willnow T. E. (1998) Receptor-associated protein (RAP): A specialized chaperone for endocytic receptors. J. Biol. Chem. 379, 1025-1031.
37. Willnow T. E., Goldstein J. L., Orth K., Brown M. S. and Herz J. (1992) Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267, 26172-26180.
38. Woodbury R. G., Brown J. P., Yeh M. Y., Hellstrom I. and Hellstrom K. E. (1980) Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc. Natl Acad. Sci. USA 77, 2183-2187.
39. Woodbury R. G., Brown J. P., Loop S. M., Hellstrom K. E. and Hellstrom I. (1981) Analysis of normal neoplastic human tissues for the tumor-associated protein p97. Int. J. Cancer 27, 145-149.
40. Yamada T., Tsujioka Y., Taguchi J., Takahashi M., Tsuboi Y., Moroo I., Yang J. and Jefferies W. A. (1999) Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease. Brain Res. 845, 1-5.
41. Zhang Y. and Pardridge W. M. (2001) Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin. Brain Res. 889, 49-56.